Cargando…

IL-21–induced Bɛ cell apoptosis mediated by natural killer T cells suppresses IgE responses

Epidemiological studies have suggested that the recent increase in the incidence and severity of immunoglobulin (Ig)E-mediated allergic disorders is inversely correlated with Mycobacterium bovis bacillus Calmette Guerin (BCG) vaccination; however, the underlying mechanisms remain uncertain. Here, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Harada, Michishige, Magara-Koyanagi, Kumiko, Watarai, Hiroshi, Nagata, Yuko, Ishii, Yasuyuki, Kojo, Satoshi, Horiguchi, Shigetoshi, Okamoto, Yoshitaka, Nakayama, Toshinori, Suzuki, Nobutaka, Yeh, Wen-Chen, Akira, Shizuo, Kitamura, Hiroshi, Ohara, Osamu, Seino, Ken-ichiro, Taniguchi, Masaru
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2118181/
https://www.ncbi.nlm.nih.gov/pubmed/17178921
http://dx.doi.org/10.1084/jem.20062206
Descripción
Sumario:Epidemiological studies have suggested that the recent increase in the incidence and severity of immunoglobulin (Ig)E-mediated allergic disorders is inversely correlated with Mycobacterium bovis bacillus Calmette Guerin (BCG) vaccination; however, the underlying mechanisms remain uncertain. Here, we demonstrate that natural killer T (NKT) cells in mice and humans play a crucial role in the BCG-induced suppression of IgE responses. BCG-activated murine Vα14 NKT cells, but not conventional CD4 T cells, selectively express high levels of interleukin (IL)-21, which preferentially induces apoptosis in Bɛ cells. Signaling from the IL-21 receptor increases the formation of a complex between Bcl-2 and the proapoptotic molecule Bcl-2–modifying factor, resulting in Bɛ cell apoptosis. Similarly, BCG vaccination induces IL-21 expression by human peripheral blood mononuclear cells (PBMCs) in a partially NKT cell–dependent fashion. BCG-activated PBMCs significantly reduce IgE production by human B cells. These findings provide new insight into the therapeutic effect of BCG in allergic diseases.